![René Rückert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
René Rückert
Chief Operating Officer at Isarna Therapeutics GmbH
Profile
René Rückert is currently the Chief Operating Officer at Isarna Therapeutics GmbH.
He started this position in 2019.
Dr. Rückert has a Master's in Business Administration from Warwick Business School and a doctorate from Charité - Universitätsmedizin Berlin.
René Rückert active positions
Companies | Position | Start |
---|---|---|
Isarna Therapeutics GmbH
![]() Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Chief Operating Officer | 31/12/2018 |
Training of René Rückert
Charité - Universitätsmedizin Berlin | Doctorate Degree |
Warwick Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Isarna Therapeutics GmbH
![]() Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Health Technology |
- Stock Market
- Insiders
- René Rückert